New adventures for the vaccine developed by AstraZeneca and the University of Oxford against Covid-19. The Berlin government recently suspended its use for women under 60, after the finding of 31 cases of thrombosis.
The vaccine had previously been suspended by the University Hospital of Berlin and other hospitals in Germany.
According to data released by the Paul Ehrlich Institute for Vaccines in Germany, they have been recorded so far. 31 cases of rare thrombosis, after vaccination with AstraZeneca preparation. Nine of the incidents ended, while with the exception of two cases, all concern women aged between 20 and 63 years. The two men were 36 and 57 years old.
The Minister of Health of the state of Berlin, Dilek Kalaitzi, also referred to these data a while ago, announcing the suspension of his use for this specific category, as reported by a response of the Athens News Agency.
A spokesman for Charité University Hospital said: “This step is necessary because new cases of thrombosis have been identified in women in Germany». However, he clarified that there was no such incident in Charité, while 16,000 doses of vaccines have already been given to the staff, most of them from AstraZeneca.
The precautionary suspension of the vaccine in women under the age of 55 was decided today by the Vivantes Hospital in Berlin, noting that the directive mainly concerns its staff.
Similar moves have already been made by hospitals in North Rhine-Westphalia, where there have even been two cases of thrombosis. A 47-year-old woman died, while a 27-year-old has since recovered.
Administration to under 55 freezes in Canada
And Canada freezes temporarily suspends AstraZeneca vaccine against covid-19 in adults under 55 years.
Health officials in the country have asked further analyzes of the benefits and risks of this vaccine by sex and age.
No cases of thrombosis have been reported in vaccinated individuals in Canada. About 307.00 doses AstraZeneca vaccine have already been granted in Canada.
“We are suspending the use of the AstraZeneca vaccine in adults under the age of 55 pending further analysis of the benefits and risks,” said Howard Zhu, his deputy chief of public health. Canada.
The National Vaccination Advisory Center (NACI), an independent panel of experts, said in a written statement that “from what we know so far there is considerable uncertainty about the benefits of administering the AstraZeneca vaccine to adults under 55 years of age.” Reuters and rebroadcasts the Athenian News Agency.
For its part, the British pharmaceutical industry responded that it respects the decision of the NACI and added that it works closely with the Canadian authorities. At the same time, AstraZeneca stressed that both the UK and the EU and the World Health Organization have ruled that the benefits of the vaccine far outweigh the risks to all adults.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
